Production (Stage)
Biocure Technology Inc.
CUREX
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 230.10K | 704.60K | 742.10K | 768.00K | 775.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 230.10K | 704.60K | 742.10K | 768.00K | 775.20K |
| Operating Income | -230.10K | -704.60K | -742.10K | -768.00K | -775.20K |
| Income Before Tax | -188.70K | -2.96M | -3.04M | -1.03M | -1.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.19 | -2.96 | -3.04 | -1.03 | -1.08 |
| Earnings from Discontinued Operations | -- | -26.80K | -26.80K | -74.80K | -256.40K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 2.10K | 2.10K | 9.40K | 20.20K |
| Net Income | -188.70K | -2.99M | -3.06M | -1.10M | -1.31M |
| EBIT | -230.10K | -704.60K | -742.10K | -768.00K | -775.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.02 | -0.29 | -0.29 | -0.11 | -0.13 |
| Normalized Basic EPS | -0.01 | -0.04 | -0.04 | -0.04 | -0.05 |
| EPS Diluted | -0.02 | -0.29 | -0.29 | -0.11 | -0.13 |
| Normalized Diluted EPS | -0.01 | -0.04 | -0.04 | -0.04 | -0.05 |
| Average Basic Shares Outstanding | 111.43M | 111.43M | 120.54M | 122.57M | 124.36M |
| Average Diluted Shares Outstanding | 111.43M | 111.43M | 120.54M | 122.57M | 124.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |